Cisplatin - Induced Hearing Loss Up for Young Children With Cancer

Cumulative incidence highest in patients aged 5 years and younger; factors that influence development include cumulative dose of cisplatin
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Family Medicine, Oncology, ENT, Pediatrics, Pharmacy, Journal, Source Type: news